Positive Phase 1 data confirm MP0317’s tumor-localized CD40 activation with a favorable safety profile in patients with advanced cancer ...

Lung cancer treatment and outcomes are profoundly influenced by the tumor microenvironment (TME), particularly in resectable ...

Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and designed to work ...

Pancreatic cancer’s deadliest trait may be its ability to stay invisible — and researchers in Rochester say they are ...

The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...

Pancreatic cancer can remain quiet for years, developing undetected before causing symptoms that lead to a diagnosis. Even ...

Researchers at Trinity College Dublin have published a major new review that brings fresh clarity to one of the deadliest ...

Human tumor organoids have advanced cancer modeling by preserving patient-specific heterogeneity and functional drug ...

New findings suggest that melanoma does not behave uniformly across the lifespan, with immune defenses and tumor activity ...